Androgen receptor modulator compounds and methods

Details for Australian Patent Application No. 2006259474 (hide)

Owner Ligand Pharmaceuticals Incorporated

Inventors Zhi, Lin; Shen, Yixing; Pedram, Bijan; Zhao, Shuo; Van Oeveren, Cornelis A.

Agent Spruson & Ferguson

Pub. Number AU-B-2006259474

PCT Pub. Number WO2006/138347

Priority 60/691,891 17.06.05 US

Filing date 12 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 27 October 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/138347 Priority application(s): WO2006/138347

27 October 2011 Application Accepted

  Published as AU-B-2006259474

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259478-Dental restorative system and components

2006259469-Multi-directional spinal stabilization systems and methods